Pharmaceuticals

Viveo prices IPO at low end

Equity IPO Brazil

Brazilian medical supplies company raises $370 mln in second IPO attempt

Richmond launches deal to finance vaccine lab

Corporate & Sovereign Strategy Debt Fixed Income

Argentine pharmaceutical company seeks to raise up to $85 mln through a financial trust

VaxThera considers future partners for clinical trials

Equity Healthcare Pharmaceuticals

Colombian vaccination company will use $54 mln from Sura to build a production plant, but it could need more investments for later stages, CEO says

Hypera acquires Sanofi brands in LatAm

M&A Healthcare Pharmaceuticals

Brazilian drugmaker agrees to spend $190 mln for 12 OTC and prescription brands in Brazil, Mexico and Colombia

Pague Menos reaches agreement to buy Extrafarma

M&A Equity Pharmaceuticals

Brazilian drugstore chain strikes a $133 mln deal to become the second largest company in the sector

Pague Menos confirms talks to buy Extrafarma

M&A Equity Pharmaceuticals

Brazilian drugstore chain could form the second largest company in the sector if it seals a deal with local conglomerate Ultrapar

Advent buys Perrigo in Latin America

M&A Equity Funds

US private equity firm will combine the acquired operations with Mexican drug maker Somar and form a company with $177 mln in revenues

Richmond seeks financing for vaccine lab

Debt Fixed Income Pharmaceuticals

Argentine pharmaceutical company to raise up to $70 mln through a green trust instrument

Vinci raises impact fund

Funds M&A ESG

Brazilian investment firm has $176 mln to buy stakes in companies with "clear" ESG goals

CDF files for IPO, Blau moves closer to pricing

Corporate & Sovereign Strategy Equity IPO

Brazilian tech support company joins the rush to the B3, while drug maker sets a target range for its offering